Bioanalysis of peptides service by Drug Development Solutions
Manufacturer Drug Development Solutions | Available Worldwide
DDS's bioanalytical solutions have helped its clients develop new peptide therapeutics to improve the quality of life. Applying their experience and cutting-edge technology, DDS has developed and validated methods using LC-MS/MS to quantify levels of peptides in plasma at levels as low as 10 pg/mL.
Bioanalysis of peptides service
.jpg.ashx?maxwidth=140&maxheight=60&bgcolor=white&mode=pad)
DDS has become experts in offering bioanalytical solutions to their clients using LC-MS/MS technology.
DDS's expertise extends beyond determination of peptide drugs in biological matrices. DDS also has experience in the quantitation of proteins (therapeutic drugs and biomarkers) as well as mAbs using DDS's BioMS™ platform.
DDS's integrated services include:
- Fast method development for discovery compounds
- Method development and validation for GLP TK studies and GCP clinical trials
- Fast turnaround for Phase I Clinical Studies
- Logistical support for clinical sample management including sample collection kit production and supply of sampling kits, labels, investigator manual and shipping
High quality reporting and data management
- Rapid turnaround of analytical data, draft and final reports, using DDS's templates or yours
- Specialist software to support SEND/SDTM data requirements
- eCTD compliant reports
- PK/TK profiling and reporting using WinNonlin™
- Certified as GLP and GCP compliant by MHRA, successful EMA audits
- Dedicated independent Quality Assurance, pharmacokinetic and data management personnel
Product Overview
Bioanalysis of peptides service
Manufacturer Drug Development Solutions | Available Worldwide
Be the first to review this product
.jpg.ashx?width=100&height=100&bgcolor=white)